Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
2.050
-0.020 (-0.97%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nucleic Acid Production | 213.27M | 214.55M | 209.33M | 224.77M | 355.23M | 478.89M | 650.88M | 813.08M | ||||||||
Nucleic Acid Production Growth | -39.96% | -55.20% | -67.84% | -72.36% | -57.52% | -43.28% | -19.82% | 14.15% | ||||||||
Biologics Safety Testing | 63.65M | 64.03M | 64.77M | 64.18M | 64.29M | 65.03M | 66.86M | 69.93M | ||||||||
Biologics Safety Testing Growth | -0.99% | -1.53% | -3.13% | -8.23% | -8.74% | -8.00% | -6.37% | 2.21% |
Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nucleic Acid Production | 70.85M | 71.98M | 64.87M | 82.66M | 194.09M | 311.31M | 483.41M | 638.34M | ||||||||
Nucleic Acid Production Growth | -63.50% | -76.88% | -86.58% | -87.05% | -70.88% | -54.42% | -25.97% | 12.93% | ||||||||
Biologics Safety Testing | 45.90M | 46.22M | 47.09M | 46.91M | 46.52M | 48.27M | 52.06M | 54.84M | ||||||||
Biologics Safety Testing Growth | -1.33% | -4.25% | -9.54% | -14.47% | -16.77% | -14.56% | -8.17% | 0.74% |
Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
North America | 132.08M | 131.91M | 133.92M | 141.06M | 174.99M | 238.19M | 293.04M | 339.47M | ||||||||
North America Growth | -24.52% | -44.62% | -54.30% | -58.45% | -50.34% | -29.64% | -10.03% | 7.07% | ||||||||
APAC | 93.60M | 95.30M | 89.21M | 97.44M | 113.10M | 99.95M | 117.97M | 109.79M | ||||||||
APAC Growth | -17.24% | -4.65% | -24.38% | -11.25% | 19.34% | 5.35% | 32.75% | 31.25% | ||||||||
EMEA | 50.53M | 50.69M | 50.30M | 49.92M | 130.78M | 204.98M | 305.87M | 432.93M | ||||||||
EMEA Growth | -61.36% | -75.27% | -83.56% | -88.47% | -71.50% | -57.84% | -36.28% | 8.86% | ||||||||
Latin and Central America | 706.00K | 686.00K | 681.00K | 527.00K | 649.00K | 798.00K | 847.00K | 808.00K | ||||||||
Latin and Central America Growth | 8.78% | -14.04% | -19.60% | -34.78% | -5.67% | 22.39% | 15.08% | -4.04% |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.